Impaired mouse mammary gland growth and development is mediated by melatonin and its MT1 G protein-coupled receptor via repression of ERα, Akt1, and Stat5

Journal of Pineal Research

Volumn 53, Issue 3, 2012, Pages 307-318

  Xiang, Shulin ^a   Mao, Lulu ^a   Yuan, Lin ^a   Duplessis, Tamika ^a   Jones, Frank ^a,b   Hoyle, Gary W ^c   Frasch, Tripp ^a   Dauchy, Robert ^a   Blask, David E ^a   Chakravarty, Geetika ^a   Hill, Steven M ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Tulane University   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

AKT; mammary gland development; melatonin; MT1 receptor; Stat5

Indexed keywords

BETA CASEIN; ESTROGEN; ESTROGEN RECEPTOR ALPHA; G PROTEIN COUPLED RECEPTOR; MELATONIN; MELATONIN 1 RECEPTOR; PROGESTERONE; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; PROTEIN KINASE B; STAT5 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; EMBRYO; EPITHELIUM CELL; FEMALE; LACTATION; MALE; MAMMARY GLAND; MOUSE MAMMARY TUMOR ONCOVIRUS; NEWBORN; NONHUMAN; ORGANOGENESIS; PREGNANCY; PROTEIN EXPRESSION;

ANIMALS; ESTROGEN RECEPTOR ALPHA; FEMALE; LACTATION; MAMMARY GLANDS, ANIMAL; MAMMARY TUMOR VIRUS, MOUSE; MELATONIN; MICE; MICE, TRANSGENIC; PREGNANCY; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, MELATONIN, MT1; STAT5 TRANSCRIPTION FACTOR;

EID: 84866248818     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2012.01000.x     Document Type: Article

References (53)

1. Lyons WR, Li CH, Johnson RE,. The hormonal control of mammary growth and lactation. Recent Prog Horm Res 1958; 14: 219-248.
2. Ferguson DJ,. Endocrine control of mammary glands in C3H mice. Surgery 1956; 39: 30-36.
3. Kleinberg DL, Feldman M, Ruan W,. IGF-1: an essential factor in terminal end bud formation and ductal morphogenesis. J Mammary Gland Biol Neoplasia 2000; 5: 7-17.
4. Brisken C, Heineman A, Chavarria T, et al., Essential function of Wnt4 in mammary gland development downstream of progesterone signaling. Genes Dev 2000; 14: 650-654. (Pubitemid 30176819)
5. Feldman M, Ruan WF, Cunningham BC, et al., Evidence that the growth hormone receptor mediates differentiation and development of the mammary glad. Endocrinology 1993; 133: 1602-1608. (Pubitemid 23295185)
6. Feldman M, Ruan W, Tappin I, et al., The effect of GH on estrogen receptor in the rat mammary gland. J Endocrinol 1999; 163: 515-522. (Pubitemid 30033747)
7. Arendt J,. Melatonin. Clin Endocrinol 1988; 29: 205-229.
8. Blask DE, Pelletier DB, Hill SM, et al., Pineal melatonin inhibition of tumor promotion in the N-nitroso-N-methylurea model of mammary carcinogenesis: potential involvement of antiestrogenic mechanisms in vivo. J Cancer Res Clin Oncol 1991; 117: 526-532.
9. Hill SM, Blask DE,. Effects of the pineal hormone on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res 1988; 48: 6121-6126. (Pubitemid 18266811)
10. Hill SM, Spriggs LL, Simon MA, et al., The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system. Cancer Lett 1992; 64: 249-256.
11. Molis T, Walters M, Hill SM,. Melatonin modulation of estrogen receptor expression in MCF-7 human breast cancer cells. Int J Oncol 1993; 3: 687-694. (Pubitemid 23296381)
12. Kiefer T, Yuan L, Spriggs LL, et al., Melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells. Breast Cancer Res Treat 2002; 71: 37-45. (Pubitemid 34121815)
13. Blask DE, Dauchy RT, Sauer LA, et al., Melatonin uptake and growth prevention in rat hepatoma 7288CTC in response to dietary melatonin: melatonin receptor-mediated inhibition of tumor linoleic acid metabolism to the growth signaling molecule 13-hydroxyoctadecadienoic acid and the potential role of phytomelatonin. Carcinogenesis 2004; 25: 951-960. (Pubitemid 38886081)
14. Fuentes-Broto L, Miana-Mena FJ, Piedrafita E, et al., Melatonin protects against taurolithocholic-induced oxidative stress in rat liver. J Cell Biochem 2010; 110: 1219-1225.
15. Kiefer TL, Lai L, Burow ME, et al., Differential regulation of estrogen receptor alpha, glucocorticoid receptor and retinoic acid receptor transcriptional activity by melatonin is mediated via the Gai2 protein. J Pineal Res 2005; 38: 231-239. (Pubitemid 41475434)
16. Hill SM, Frasch T, Xiang S, et al., Molecular mechanisms of melatonin anticancer effects. Integr Cancer Ther 2009; 8: 337-346.
17. Wu J, Dauchy RT, Tirrell PC, et al., Light at night activates IGF-1R/PDK1 signaling and accelerates tumor growth in human breast tumor xenografts. Cancer Res 2011; 71: 2622-2631.
18. Becker-André M, Wiesenberg I, Schaeren-Wiemers N, et al., Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J Biol Chem 1994; 269: 28531-28534. (Pubitemid 24366678)
19. Becker-Andre M, Wiesenberg I, Schaeren-Wiemers N, et al., Pineal gland hormone melatonin binds and activates an orphan receptor of the nuclear receptor superfamily. J Biol Chem 1997; 272: 16707.
20. Morgan PJ, Barrett P, Howell HE, et al., Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem Int 1994; 24: 101-146. (Pubitemid 24061864)
21. Yuan L, Collins A, Dai J, et al., MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells. Mol Cell Endocrinol 2002; 192: 147-156. (Pubitemid 34667233)
22. Mediavilla MD, San Martín M, Alonso-González C, et al., Melatonin inhibits mammary gland development in female mice. J Pineal Res 1992; 13: 13-19.
23. Mediavilla MD,. Melatonin prevents the estrogenic effects of sub-chronic administration of cadmium on mice mammary glands and uterus. J Pineal Res 2007; 42: 403-410. (Pubitemid 46581665)
24. Zhuo Y, Hoyle GW, Shan B, et al., Over-expression of PDGF-C using a lung specific promoter results in abnormal lung development. Transgenic Res 2006; 15: 543-555. (Pubitemid 44401436)
25. Aupperlee MD, Haslam SZ,. Differential hormonal regulation and function of progesterone receptor isoforms in normal adult mouse mammary gland. Endocrinology 2007; 148: 2290-2300. (Pubitemid 46997067)
26. Manning BD, Cantley LC,. AKT/PKB signaling: navigating downstream. Cell 2007; 129: 1261-1274. (Pubitemid 46962095)
27. Maroulakou IG, Oemler W, Nuber SP, et al., Distinct roles of the three Akt isoforms in lactogenic differentiation. J Cell Physiol 2008; 217: 468-477.
28. Feng Y, Nanka D, Wagner KU, et al., Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice. Proc Natl Acad Sci USA 2007; 104: 14718-14723. (Pubitemid 350003209)
29. Conti A, Maestroni GJ,. HPLC validation of a circadian melatonin rhythm in the pineal gland of inbred mice. J Pineal Res 1996; 20: 138-144. (Pubitemid 126733169)
30. Conti A, Haran-Ghera N, Maestroni GJ,. Role of pineal melatonin and melatonin-induced-immuno-opiods in murine leukemogenesis. Med Oncol Tumor Pharmacother 1992; 9: 87-92.
31. Connor EE, Meyer MJ, Li RW, et al., Regulation of gene expression in the bovine mammary gland by ovarian steroids. J Dairy Sci 2007; 90: E55-E65.
32. Shyamala G, Louie SG, Camarillo IG, et al., The progesterone receptor and its isoforms in mammary development. Mol Genet Metab 1999; 68: 182-190. (Pubitemid 29501089)
33. Fendrick JL, Raafat AM, Haslam SZ,. Mammary gland growth from the postnatal period to postmenopause: ovarian steroid receptor ontogeny and regulation in the mouse. J Mammary Gland Biol Neoplasia 1998; 3: 7-22. (Pubitemid 128513216)
34. Ruan W, Monaco ME, Kleinber DL,. Progesterone stimulates mammary gland ductal morphogenesis by synergizing with and enhancing insulin-like growth factor-1 action. Endocrinology 2005; 146: 1170-1178. (Pubitemid 40289306)
35. Lai L, Yuan L, Dong C, et al., The Galphai and Galphaq proteins mediate the effects of melatonin on steroid/thyroid hormone receptor transcriptional activity and breast cancer cell proliferation. J Pineal Res 2008; 45: 476-488.
36. Hill SM, Blask DE, Xiang S, et al., Melatonin and associated signaling pathways that control breast epithelium and breast cancer. J Mammary Gland Biol Neoplasia 2011; 16: 235-245.
37. Reichardt HM, Horschg K, Grone HJ, et al., Mammary gland development and lactation are controlled by different glucocorticoid receptor activities. Eur J Endocrinol 2001; 145: 519-527. (Pubitemid 32927082)
38. Stocklin E, Wissler M, Gouilleux F, et al., Functional interactions between Stat5 and the glucocorticoid receptor. Nature 1996; 383: 726-728. (Pubitemid 26360650)
39. Blask DE, Hill SM, Dauchy RT, et al., Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night. J Pineal Res 2011; 51: 259-269.
40. Proietti S, Cucina A, D'Anselmi F, et al., Melatonin and vitamin D3 synergistically down-regulate Akt and MDM2 leading to TGFβ-1-dependent growth inhibition of breast cancer cells. J Pineal Res 2011; 50: 150-158.
41. Lemus-Wilson A, Kelly PA, Blask DE,. Melatonin blocks the stimulatory effect of prolactin on human breast cancer cell growth in culture. Br J Cancer 1995; 72: 1435-1440. (Pubitemid 26002654)
42. Burdon T, Wall JR, Shamay A, et al., Over-expression of an endogenous milk protein gene in transgenic mice is associated with impaired mammary gland alveolar development and a milchlos phenotype. Mech Dev 1991; 36: 67-74.
43. Astigiano S, Damonte P, Babieri O,. Inhibition of ductal morphogenesis in the mammary gland of WAP-fgf4 transgenic mice. Anat Embryol 2003; 206: 471-478. (Pubitemid 36693768)
44. Li S, Rosen JM,. Nuclear factor 1 and mammary gland factor (STAT5) play a critical role in regulating rat whey acidic protein gene expression in transgenic mice. Mol Cell Biol 1995; 15: 2063-2070.
45. Miyoshi K, Shillingford JM, Smith GH, et al., Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium. J Cell Biol 2001; 155: 531-542. (Pubitemid 34289312)
46. Wagner KU, Krempler A, Triplett AA, et al., Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice. Mol Cell Biol 2004; 24: 5510-5520. (Pubitemid 38738182)
47. Lin DI, Lessie MD, Gladden AB, et al., Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis. Oncogene 2008; 27: 1231-1242. (Pubitemid 351294688)
48. Creamer BA, Sakamoto K, Schmidt JW, et al., Stat5 promoters survival of mammary epithelial cells through transcriptional activation of a distinct promoter for Akt1. Mol Cell Biol 2010; 30: 2957-2970.
49. Hovey RC, Trott JF, Vanderhaar BK,. Establishing a framework for the functional mammary gland: from endocrinology to morphology. J Mammary Gland Biol Neoplasia 2002; 7: 17-38. (Pubitemid 38420779)
50. Silbertein GB,. Postnatal mammary gland morphogenesis. Microsc Res Tech 2001; 52: 155-162.
51. Parmar H, Cunha GR,. Epithelial-stromal interactions in the mouse and human mammary gland in vitro. Endocr Relat Cancer 2004; 11: 437-458. (Pubitemid 39331276)
52. Richards RG, Klotz DM, Walker MP, et al., Mammary gland branching morphogenesis is diminished in mice with a deficiency of insulin-like growth factor-1 (IGF-1), but not mice with a liver-specific deletion of IGF-1. Endocrinology 2004; 145: 3106-3110. (Pubitemid 38829978)
53. Mueller SO, Clark JA, Myers PH, et al., Mammary gland development in adult mice requires epithelial and stromal estrogen receptor alpha. Endocrinology 2002; 143: 2357-2365. (Pubitemid 34521582)